Attached files
| file | filename |
|---|---|
| 8-K/A - FORM 8-K/A AMENDED CURRENT REPORT - Global Medical REIT Inc. | f8ka091214_8kz.htm |
| EX-99.2 - EXHIBIT 99.2 - Global Medical REIT Inc. | f8ka091214_ex99z2.htm |
| EX-99.1 - EXHIBIT 99.1 - Global Medical REIT Inc. | f8ka091214_ex99z1.htm |
EXHIBIT 99.3
GLOBAL MEDICAL REIT, INC.
UNAUDITED PRO FORMA STATEMENT OF ESTIMATED TAXABLE OPERATING RESULTS AND CASH TO BE MADE AVAILABLE BY OPERATIONS FOR THE PERIOD ENDED FEBRUARY 28, 2014 AND THE YEAR ENDED AUGUST 31, 2013
The following is additional information provided in respect of Rule 3-14 of Regulation S-X and represents an estimate of the taxable operating results and cash to be made available by operations of Global Medical REIT, Inc. (inclusive of the impact of the Facility Acquisition) based upon the pro forma condensed combined statement of operations for the for the six months ended February 28, 2014 and year ended August 31, 2013. There were no book to tax differences for the and for the six months ended February 28, 2014 and year ended August 31, 2013 and as a result there are no material differences between taxable loss and net loss. These estimated results do not purport to represent results of operations in the future and were prepared based on the assumptions outlined in the pro forma condensed combined statement of operations, which should be read in conjunction with this statement.
For the Six Months Ended February 28, 2014
|
| Pro Forma | |
Net loss |
| $ | (156,746) |
Adjustments: |
|
|
|
Depreciation |
|
| 278,333 |
Amortization of deferred financing costs |
|
| 45,532 |
Estimated cash to be made available from operations |
| $ | 167,119 |
Estimated cash to be used in investing activities |
|
| - |
Estimated cash to be used in financing activities (1) |
|
| - |
Estimated difference between cash available for distribution and the estimated distributions for six months ending February 28, 2014 |
|
| - |
Estimated annual distributions to stockholders (2) |
| $ | 167,119 |
Estimated annual distributions per share |
| $ | 0.00 |
(1)
Assumes financing activities will be zero as the Company will draw on the Heng Fai loan to pay principal payments for mortgage debt.
(2)
100% of the cash distribution estimated to be return of capital
For the Period Ended August 31, 2013
|
| Pro Forma | |
Net loss |
| $ | (364,563) |
Adjustments: |
|
|
|
Depreciation |
|
| 556,667 |
Amortization of deferred financing costs |
|
| 91,064 |
Estimated cash to be made available from operations |
| $ | 283,168 |
Estimated cash to be used in investing activities |
|
| - |
Estimated cash to be used in financing activities (1) |
|
| - |
Estimated difference between cash available for distribution and the estimated distributions for six months ending February 28, 2014 |
|
| - |
Estimated annual distributions to stockholders (2) |
| $ | 283,168 |
Estimated annual distributions per share |
| $ | 0.00 |
(1)
Assumes financing activities will be zero as the Company will draw on the Heng Fai loan to pay principal payments for mortgage debt.
(2)
100% of the cash distribution estimated to be return of capital